T
terzepatide
Productby Eli Lilly and Company
Heard in 10 episodes across 7 shows since Sep 2026
Tirzepatide is an injectable medicine that activates GIP and GLP-1 receptors and is used to treat type 2 diabetes and chronic weight management.
Discussed inMarkets69%Health & Science23%Culture8%
Episodes
10
across 7 shows
This week
0
episodes on 0 shows
Share of the conversation
Mentions of terzepatide per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Sep 12 | 0.01‰ | 1 |
| Sep 26 | 0.01‰ | 1 |
| Sep 28 | 0.03‰ | 2 |
| Oct 16 | 0.01‰ | 1 |
| Oct 20 | 0.02‰ | 1 |
| Oct 28 | 0.02‰ | 2 |
| Oct 29 | 0.03‰ | 1 |
| Oct 31 | 0.03‰ | 1 |
| Nov 1 | 0.05‰ | 2 |
| Nov 2 | 0.09‰ | 5 |
Email alert
Email me when terzepatide comes up on a podcast
One email a week at most, with the new episodes that mention terzepatide. Free, no account needed, unsubscribe in one click.
Episodes
10 episodes featuring terzepatide, newest first
- Nov 2, 2026
Comey case tests limits of politicized prosecutionBloomberg LawNov 2, 2026 - Nov 1, 2026
Investors test Novo, Moody’s, and Deckers against bear casesThe Investor's Podcast (We Study Billionaires) - The Investor’s Podcast NetworkNov 1, 2026 - Oct 31, 2026
Mind Pump separates fitness skills from strength trainingMind Pump: Raw Fitness TruthOct 31, 2026 - Oct 29, 2026
GLP-1 microdosing outruns the evidenceScience FridayOct 29, 2026 - Oct 28, 2026Lilly targets copycat retatrutide as families seek accountabilityBloomberg LawOct 28, 2026
- Oct 20, 2026
Karen and Wendy clash over sobriety and accountabilityWatch What CrappensOct 20, 2026